The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem ...
"Good Morning America" co-anchor Robin Roberts is marking 12 years since she returned to the anchor desk after receiving a lifesaving stem cell transplant to treat myelodysplastic syndrome ...
Transplantation of neural stem cells improved ... New research has determined that neural stem cell implants improve outcomes at 12 months for those suffering chronic stroke.
Feb. 4, 2025 — Research has shown that a potential new targeted therapy for childhood brain cancer is effective in infiltrating and killing tumor cells in preclinical models tested in mice.
Sekeres, MD, Sylvester Comprehensive Cancer Center, discusses the potential benefits of treosulfan, a newly approved agent for allogeneic hematopoietic stem cell transplantation (allo-HSCT ...
Olalekan O Oluwole, MD, MBBS, discusses the background and rationale of the research he contributed to, which was presented at the 2025 Transplantation & Cellular Therapy Meetings. CAR T-cell therapy ...
Stem-cell research is the area of research that studies the properties of stem cells and their potential use in medicine. As stem cells are the source of all tissues, understanding their ...
Cellistic, a pioneer in iPSC-based off-the-shelf cell therapy development and manufacturing services, announces the launch of its Allo Chassis ... induced pluripotent stem cell (iPSC) technology ...
Leveraging Cellistic's extensive expertise in iPSCs, including in the development of T-cell based treatments, the Allo Chassis™ cell lines set a new standard in the cell therapy market with ...
MONT-SAINT-GUIBERT, Belgium--(BUSINESS WIRE)--Cellistic, a pioneer in iPSC-based off-the-shelf cell therapy development and manufacturing services, announces the launch of its Allo ...
MONT-SAINT-GUIBERT, Belgium–(BUSINESS WIRE)–Cellistic, a pioneer in iPSC-based off-the-shelf cell therapy development and manufacturing services, announces the launch of its Allo Chassis™—ready-to-use ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果